to maximize their impact on human health
needed to solve medicine's most challenging problems
meaningful clinical benefit and growing further discovery
The Latest News
-
Ruoslahti is the first Institute researcher to ever win the Lasker Award, known as “America’s Nobel” -
Professor Peter Adams named Mentor of the Year, a new honor from the Institute’s Office of Education, Training and International Services (OETIS) and the Postdoctoral Training Advisory Group (PTAG). The award was announced at the 21st annual Trainee Research Symposium. -
Drug Discovery
Sanford Burnham Prebys researchers awarded $6.4M to advance treatment for substance use disorders
Their research has shown promise for tobacco use — now they’re tackling another epidemic -
The Board of Directors of Sanford Burnham Prebys is pleased to announce the appointment of David Brenner, M.D., as the Institute’s next president and chief executive officer. -
Genetic Disorders and Aging
How a single protein could unlock age-related vision loss
Research led by Sanford Burnham Prebys professor Francesca Marassi, Ph.D., is helping to reveal the molecular secrets of macular degeneration, which causes almost 90% of all age-related vision loss. -
Institute researchers have shown for the first time that inhibiting a key metabolic enzyme selectively kills melanoma cells and stops tumor growth. -
Genetic Disorders and Aging
Using stem cells to study the biochemistry of learning
A method for studying human neurons could help researchers develop approaches for treating Alzheimer’s, schizophrenia and other neurological diseases -
Genetic Disorders and Aging
Peter Adams and Bing Ren awarded $10.6M to create atlas of aging cells
The multi-institution initiative will reveal new insights into the aging process and uncover targets to promote health across the life span -
Monarch butterflies were recently declared endangered, so the Institute is planting Milkweed to help support their repopulation. -
Education
New internship program ignites a SPARK
For the first time, Sanford Burnham Prebys hosted high school interns from the SPARK program, an initiative by the California Institute for Regenerative Medicine (CIRM) that provides biomedical research opportunities for underrepresented groups throughout California. -
Genetic Disorders and Aging
Timothy Huang awarded $2.8M to study well-known gene linked to Alzheimer’s disease
Timothy Huang, Ph.D., has been awarded $2.8 million by the National Institute on Aging (NIA) to continue his work on Alzheimer’s disease. The four-year project will use human stem cells transplanted into mice to determine the role of specific Alzheimer’s-related gene mutations in the brain. -
This year's Preuss internship program was hosted by the Institue's NCI-designated Cancer Center.
Living History
NCI-Designated Cancer Center
Earning the NCI designation in 1981 — just five years after its modest start in downtown La Jolla — our Cancer Center truly is "the miracle on Torrey Pines Mesa."
Next Generation
Svasti Haricharan and Brooke Emerling featured in GEN
Svasti Haricharan, Ph.D. and Brooke Emerling, Ph.D. are leveraging cellular signaling to potentially change the way we treat breast cancer.
Living History
Along the road to discovery
It was in 1979 when Eva Engvall asked Erkki Ruoslahti a question that would change their lives forever: "Wouldn't it be great to work in San Diego?"
Next Generation
Graduate student Katja Birker's research doesn't miss a beat
"There is no magic wand to cure congenital heart conditions–we have to do the research."
Our Partners in Discovery
We can't do it alone
Our annual Rare Disease Day symposium strengthens the global network of families, physicians and researchers to better understand and fight rare diseases in children.
Our Partners in Discovery
Getting to the finish line faster
Thanks to the philanthropic vision of Stuart and Karen Tanz, a unique collaboration seeks new treatments for diseases such as Alzheimer’s, dementia and Parkinson’s.
Our Partners in Discovery
New hope for autoimmune disease
Our partnership with Lilly—centered around a high degree of interaction—has already produced an immune therapy now in clinical trial.
Our Partners in Discovery
A master class in collaboration
Meet T. Denny Sanford, Conrad Prebys and Malin Burnham: three people who know we're stronger when we work together.
